33rd Ordinary Annual General Meeting of RHÖN-KLINIKUM AG

At today’s Annual General Meeting (AGM) of RHÖN-KLINIKUM AG the shareholders approved the proposal by the Board of Management and Supervisory Board not to distribute a dividend for the past financial year 2020. Due to the ongoing uncertainties with regard to the further effects of the COVID 19 pandemic on the earnings and liquidity situation, the Board of Management and Supervisory Board had proposed to the AGM to carry forward the full net distributable profit of approx. Euro 193.2 million. Retaining the net distributable profit will strengthen the capital and liquidity base and safeguard the capability of RHÖN-KLINIKUM AG to make investments.

Apart from the resolution on the appropriation of the net distributable profit and the election of a Supervisory Board member, the agenda also included resolutions on the formal approval of the actions of the Board of Management and Supervisory Board for financial year 2020 and on the new remuneration system for the Board of Management. The shareholders approved all the items on the agenda. The actions of the Board of Management and Supervisory Board for financial year 2020 were approved by a clear majority.

Appeal for a National Policy to Safeguard Acceptable Medical Care
In addition to commenting on the development of financial year 2020 and the first quarter of 2021, on which RHÖN-KLINIKUM AG has already reported in detail (see Corporate News of 25th March 2021 and 6th May 2021), the Board of Management now reported on the required reforms in the German healthcare system.

The Board of Management of RHÖN-KLINIKUM AG has repeatedly articulated its requests in many discussions with national and federal state politicians. Such requests include lessening the bureaucracy in required documentation and also reducing the overall amount of documentation, the adequate financing of investments, binding planning certainty and full compensation of lost earnings for 2021, including all types of revenues and expenses, as well as overhauling the German hospital landscape pursuant to structured and transparent criteria.

"We have been heard, now it is up to the politicians to set the necessary reforms in motion. But unfortunately political mills grind very slowly and it is also necessary to correct the failures of past decades," Dr. Christian Höftberger, CEO of RHÖN-KLINIKUM AG, stated.

Marco Walker Elected to Supervisory Board
Marco Walker, 45, COO of Asklepios Kliniken GmbH & Co. KGaA, Hamburg, and Managing Director of Asklepios Kliniken Management GmbH, was elected to the Supervisory Board of RHÖN-KLINIKUM AG. He succeeds Prof. Dr. Gerhard Ehninger who resigned his mandate and left the Company’s Supervisory Board on 15th January 2021. Walker was appointed as a member of the Company’s Supervisory Board by order of the Amtsgericht (local court) in Schweinfurt on 3rd March 2021. Today the shareholders elected him to the board as a shareholder representative.

New Remuneration System for Board of Management
Furthermore the AGM approved a new remuneration system for the Board of Management which was developed by the Supervisory Board and adopted in March 2021. The remuneration system for the Board of Management will apply from 1st April 2021. RHÖN-KLINIKUM AG is thus putting into practice the amended regulatory requirements on Board of Management remuneration in line with the Act Implementing the Second Shareholders‘ Rights Directive (Gesetz zur Umsetzung der zweiten Aktionärsrechterichtlinie – ARUG II). The remuneration system is an incentive for effective and sustainable corporate management. It specifies a maximum level of remuneration and contains detailed provisions for both fixed and variable remuneration elements. You can find the voting results and the CEO report for today’s AGM under www.rhoen-klinikum-ag.com/agm.

The 2020 Annual Report is available at www.rhoen-klinikum-ag.com/annualreport.

Follow us: www.twitter.com/rhoenklinikumag 
www.xing.com/companies/rhön-klinikumag 
www.youtube.com/rhönklinikumag